{
  "slug": "bristol-myers-squibb-bms",
  "name": "Bristol Myers Squibb (BMS)",
  "description": "Bristol Myers Squibb (BMS) is a global biopharmaceutical company that discovers, develops, and delivers innovative medicines to help patients prevail over serious diseases. It is one of the world's largest pharmaceutical companies, consistently ranking on the Fortune 500 list, with a primary focus on oncology, cardiovascular, immunology, and fibrotic diseases.",
  "url": "https://optimly.ai/brand/bristol-myers-squibb-bms",
  "logoUrl": "",
  "baiScore": 92,
  "archetype": "Challenger",
  "category": "Healthcare",
  "categorySlug": null,
  "keyFacts": [],
  "aiReadiness": [],
  "competitors": [
    {
      "slug": "abbvie",
      "name": "Abbvie"
    },
    {
      "slug": "novartis",
      "name": "Novartis"
    },
    {
      "slug": "pfizer",
      "name": "Pfizer"
    }
  ],
  "inboundCompetitors": [],
  "aiAlternatives": [],
  "parentBrand": null,
  "subBrands": [],
  "updatedAt": "2026-04-10T20:23:10.842+00:00",
  "verifiedVitals": {
    "website": "https://www.bms.com",
    "founded": "1887 (Bristol-Myers), 1858 (Squibb), 1989 (Merger)",
    "headquarters": "Princeton, New Jersey, USA",
    "pricing_model": "Enterprise/Healthcare Provider (Insurance-reimbursed)",
    "core_products": "Opdivo, Eliquis, Revlimid, Orencia, Pomalyst, Camzyos, Breyanzi",
    "key_differentiator": "One of the most robust pipelines in the industry specifically focused on the high-barrier high-reward fields of oncology and precision medicine.",
    "target_markets": "Healthcare systems, hospitals, pharmacies, government health agencies, and global patient populations.",
    "employee_count": "~34,000 (subject to 2024 restructuring)",
    "funding_stage": "Public (NYSE: BMY)",
    "subcategory": "Biopharmaceuticals"
  },
  "intentTags": {
    "problemIntents": [
      "In-house Research Institutions: Large academic medical centers or specialized hospitals developing their own cell therapies or treatment protocols.",
      "Full-service CROs: Hiring contract research organizations (CROs) to handle drug discovery and clinical trials rather than a full-service biopharma partner."
    ],
    "solutionIntents": [
      "top oncology pharmaceutical companies",
      "who makes Eliquis",
      "leading immunology drug developers",
      "biopharma companies in New Jersey",
      "best treatments for schizophrenia 2024",
      "Generic Manufacturers: Relying on older generations of generic drugs or non-patented treatments after a brand-name drug's patent expires."
    ],
    "evaluationIntents": []
  },
  "timestamp": 1776038105855
}